Professor Ioanna Gouni-Berthold, University of Cologne, Germany, discusses recently published and ongoing studies of antisense oligonucleotides, small interfering RNAs and small molecules targeting Lp(a).
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.